Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
775
datasets available to search
ShareScore release 0.9.0
Dataset results
775 results for “irinotecan”
A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.
ClinicalTrials.gov study NCT00034502. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer
ClinicalTrials.gov study NCT05595889. IPD Sharing: NO. Countries: 0. Publications: 0.
Liposomal Irinotecan With Cisplatin and Concurrent Radiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06491134. IPD Sharing: NO. Countries: 0. Publications: 0.
Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Cancer
ClinicalTrials.gov study NCT06571461. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer
ClinicalTrials.gov study NCT06462105. IPD Sharing: YES. Countries: 0. Publications: 0.
Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT05047991. IPD Sharing: NO. Countries: 0. Publications: 0.
Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)
ClinicalTrials.gov study NCT05255666. IPD Sharing: NO. Countries: 0. Publications: 0.
JSKN003 Versus Physician Choiced Treatment in Patients With HER2-positive and Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-Fu, and Irinotecan
ClinicalTrials.gov study NCT07384377. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Liposomal Irinotecan and Capecitabine Plus Bevacizumab as Second-line Therapy in Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT06192680. IPD Sharing: NO. Countries: 0. Publications: 0.
A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI Tumours
ClinicalTrials.gov study NCT00220064. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Trabectedin and Irinotecan for Refractory Pediatric Sarcomas
ClinicalTrials.gov study NCT02509234. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung Cancer
ClinicalTrials.gov study NCT03651219. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases
ClinicalTrials.gov study NCT01939483. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Irinotecan Liposome,Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic Cancer
ClinicalTrials.gov study NCT06513455. IPD Sharing: NO. Countries: 0. Publications: 0.
Efficacy and Safety of Anlotinib, Irinotecan and Temozolomide in the Treatment of Refractory or Recurrent Neuroblastoma in Children: an Open, Single Arm, Single Center, Phase II Clinical Study
ClinicalTrials.gov study NCT04842526. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Liposomal Irinotecan Combined with Sintilimab for Second-line Treatment of Progressive Gastric Cancer
ClinicalTrials.gov study NCT06697366. IPD Sharing: NO. Countries: 0. Publications: 0.
Exploratory Study of Irinotecan Liposomes in Maintenance Therapy of Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT06341309. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Efficacy and Safety of SBRT Followed by Tislelizumab Plus Cetuximab and Irinotecan in Patients With Previously Treated RAS Wild-type Advanced Refractory Colorectal Cancer
ClinicalTrials.gov study NCT05799443. IPD Sharing: NO. Countries: 0. Publications: 0.
Venetoclax and Irinotecan in Relapsed/Refractory SCLC
ClinicalTrials.gov study NCT04543916. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g)
ClinicalTrials.gov study NCT00497497. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.